Liam Grogan

1.7k total citations
66 papers, 978 citations indexed

About

Liam Grogan is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Liam Grogan has authored 66 papers receiving a total of 978 indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Oncology, 22 papers in Pulmonary and Respiratory Medicine and 16 papers in Pathology and Forensic Medicine. Recurrent topics in Liam Grogan's work include Cancer Treatment and Pharmacology (8 papers), Gastric Cancer Management and Outcomes (7 papers) and Colorectal Cancer Treatments and Studies (7 papers). Liam Grogan is often cited by papers focused on Cancer Treatment and Pharmacology (8 papers), Gastric Cancer Management and Outcomes (7 papers) and Colorectal Cancer Treatments and Studies (7 papers). Liam Grogan collaborates with scholars based in Ireland, United States and Australia. Liam Grogan's co-authors include Ilan R. Kirsch, Carmen J. Allegra, Oscar S. Breathnach, Kenneth Nakahara, Eileen Dimond, Bryan T. Hennessy, Patrick G. Morris, Seth M. Steinberg, Peter W. Soballe and Jean Jenkins and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and British Journal of Cancer.

In The Last Decade

Liam Grogan

62 papers receiving 953 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Liam Grogan Ireland 18 424 281 253 164 143 66 978
Michael Koenigsmann Germany 20 436 1.0× 227 0.8× 165 0.7× 290 1.8× 80 0.6× 63 1.5k
Amit Sud United Kingdom 15 244 0.6× 361 1.3× 211 0.8× 102 0.6× 285 2.0× 37 962
Claudio Cerchione Italy 20 585 1.4× 574 2.0× 167 0.7× 129 0.8× 58 0.4× 123 1.3k
Ulf Petrausch Switzerland 23 1.1k 2.6× 289 1.0× 132 0.5× 289 1.8× 115 0.8× 62 1.6k
Luca Lo Nigro Italy 27 290 0.7× 581 2.1× 185 0.7× 103 0.6× 106 0.7× 101 2.1k
Richard Champlin United States 19 638 1.5× 332 1.2× 161 0.6× 78 0.5× 77 0.5× 52 1.7k
Hans‐Christian Kolberg Germany 15 480 1.1× 247 0.9× 122 0.5× 205 1.3× 76 0.5× 84 966
Elizabeth B. Harvey United States 13 446 1.1× 262 0.9× 238 0.9× 210 1.3× 98 0.7× 16 1.3k
Maria Del Pilar Estevez-Diz Brazil 20 553 1.3× 312 1.1× 116 0.5× 148 0.9× 139 1.0× 82 1.2k
Yung‐Chang Lin Taiwan 19 664 1.6× 273 1.0× 86 0.3× 167 1.0× 38 0.3× 49 1.3k

Countries citing papers authored by Liam Grogan

Since Specialization
Citations

This map shows the geographic impact of Liam Grogan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liam Grogan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liam Grogan more than expected).

Fields of papers citing papers by Liam Grogan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liam Grogan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liam Grogan. The network helps show where Liam Grogan may publish in the future.

Co-authorship network of co-authors of Liam Grogan

This figure shows the co-authorship network connecting the top 25 collaborators of Liam Grogan. A scholar is included among the top collaborators of Liam Grogan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liam Grogan. Liam Grogan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Roy, Gargi, Bryan T. Hennessy, Oscar S. Breathnach, et al.. (2025). Cutaneous Immune‐Related Adverse Events and Efficacy of Immune Checkpoint Inhibitors for Patients With Advanced Solid Organ Malignancies. International Journal of Dermatology. 65(4). 790–796.
2.
3.
Sørensen, Jan, et al.. (2024). Salvage surgery for oesophageal cancer: The need for more intensive surveillance. European Journal of Surgical Oncology. 51(3). 109548–109548. 1 indexed citations
4.
Rashed, Ahmed Nabih Zaki, David J. Easty, Dearbhaile Catherine Collins, et al.. (2023). An observational study of dose dense chemotherapy with lipegfilgrastim support in early breast cancer. BMC Cancer. 23(1). 171–171. 1 indexed citations
5.
Jansen, Michael, et al.. (2022). Case report: BRAF-inhibitor therapy in BRAF-mutated primary CNS tumours including one case of BRAF-mutated Rosai-Dorfman disease. Frontiers in Medicine. 9. 1070828–1070828. 2 indexed citations
6.
Dunne, Mary, et al.. (2022). Oesophageal cancer metastases: An observational study of a more aggressive approach. World Journal of Gastrointestinal Surgery. 14(9). 997–1007. 2 indexed citations
7.
Newman, Christine, et al.. (2021). Multiple endocrinopathies, hypercalcaemia and pancreatitis following combined immune checkpoint inhibitor use- case report and review of literature. BMC Endocrine Disorders. 21(1). 33–33. 8 indexed citations
8.
Farrelly, Angela M., Mattia Cremona, Paul A. Armstrong, et al.. (2021). Targeting the PI3K and MAPK pathways to improve response to HER2-targeted therapies in HER2-positive gastric cancer. Journal of Translational Medicine. 19(1). 184–184. 28 indexed citations
9.
Barrett, Fiona, et al.. (2021). Chemotherapy in the Covid-19 era: the patient’s perception. Irish Journal of Medical Science (1971 -). 190(4). 1303–1308. 12 indexed citations
10.
Toomey, Sinéad, Stephen F. Madden, Michelle Casey, et al.. (2020). Use of exhaled breath condensate (EBC) in the diagnosis of SARS-COV-2 (COVID-19). Thorax. 76(1). 86–88. 57 indexed citations
11.
Hennessy, Martina, et al.. (2020). 1571P Chemotherapy in the COVID-19 era: The patient’s perception. Annals of Oncology. 31. S957–S957. 1 indexed citations
12.
Ó’Riain, Ciarán, Sinéad Toomey, Kirsten M. Timms, et al.. (2020). Prevalence of tumor BRCA1 and BRCA2 dysfunction in unselected patients with ovarian cancer. Obstetrics & Gynecology Science. 63(5). 643–654. 6 indexed citations
13.
Keane, Fergus, Niamh M. Keegan, Philip J. O’Halloran, et al.. (2019). Similar overall survival with reduced vs. standard dose bevacizumab monotherapy in progressive glioblastoma. Cancer Medicine. 9(2). 469–475. 17 indexed citations
14.
Collins, Dearbhaile Catherine, Megan L. Coghlan, Bryan T. Hennessy, et al.. (2016). The impact of outpatient systemic anti-cancer treatment on patient costs and work practices. Irish Journal of Medical Science (1971 -). 186(1). 81–87. 4 indexed citations
15.
Lennon, Olive, et al.. (2013). Chemotherapy induced peripheral neuropathy: the modified total neuropathy score in clinical practice. Irish Journal of Medical Science (1971 -). 183(1). 53–58. 24 indexed citations
16.
Korpanty, Grzegorz, et al.. (2012). Bronchoesophageal Fistula in a Patient With Stage IIIB Non–Small-Cell Lung Cancer. Journal of Thoracic Oncology. 7(10). 1622–1622. 3 indexed citations
17.
O’Hare, Alan, et al.. (2010). 20 YEAR OLD LADY WITH A PARASPINAL MASS. Brain Pathology. 20(3). 683–684. 1 indexed citations
18.
Grogan, Liam, et al.. (1994). Bcl-2 Rearrangement in Hodgkin’s Disease and Reactive Lymph Nodes. American Journal of Clinical Pathology. 101(6). 756–760. 21 indexed citations
19.
Grogan, Liam, et al.. (1994). Preclinical and clinical aspects of biomodulation of 5-fluorouracil. Cancer Treatment Reviews. 20(1). 11–49. 81 indexed citations
20.
Grogan, Liam, et al.. (1992). The detection of specific gene rearrangements in non-Hodgkin's lymphoma using the polymerase chain reaction. British Journal of Cancer. 66(5). 805–809. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026